Cover image of the article: Study of colorectal polyps using 1H Nuclear Magnetic Resonance spectroscopy

Image Credit:Koomesh

Study of colorectal polyps using 1H Nuclear Magnetic Resonance spectroscopy

Authors

sedigheh sadeghi, ayda iravani, mohammad arjmand, farideh vahabi, syedmahmood eshaghhoseini, akbar oghalai, fatemeh mirkhani, Zahra Zamani,*
*Corresponding Author: Email: zamani@pasteur.ac.ir

Koomesh:Vol. 17, issue 4; 974-980
Published online:Sep 28, 2016
Article type:Research Article
Received:Jun 01, 2014
Accepted:Jan 01, 2016
How to Cite:sadeghi S, iravani A, arjmand M, vahabi F, eshaghhoseini S, et al. Study of colorectal polyps using 1H Nuclear Magnetic Resonance spectroscopy. koomesh. 2016;17(4):e151192. doi:

Abstract

Introduction: The patients with polyps and ulcerative colitis diagnosis are more susceptible to colorectal cancer. So far, the diagnosis of colorectal diseases has been dependent on invasive procedures, such as sigmoidoscopy and colonoscopy. However, some recent research has been initiated for early diagnosis of colon cancer by using1H nuclear magnetic resonance (1H NMR) spectroscopy and chemometrics methods. In this study, spectrum results of patients and samples of normal subjects were compared. Materials and Methods: Participants who referred for colonoscopy (n=40) filled a consent form.They had received liquid diets for last 72 hours. Blood samples were collected in heparinized tubes. Samples were collected from patients who were diagnosed with polyps and also normal subjects. The separated plasma samples were sent for 1HNMR spectroscopy using CPMG Spin-echo methods. The samples were analyzed using ProMetab software, with performance of Principle Component Analysis.  The different metabolites were identified by their chemical shifts. Results: There were 1624 metabolites in each spectrum. Effective metabolites were detected using Human Metabolome Data Base and effective metabolic cycle were determined using metaboanalyst Data Base. Conclusion: These findings indicated that the metabolism of amino acid tRNA synthase, histidine, cyanoamine and thiamine are the main differentiating metabolic cycles involved in the production of colorectal polyp.

Highlights

References

  • 1.
    Wong CK, Fedorak RN, Prosser CI, Stewart ME, van Zanten SV, Sadowski DC. The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer. Int J Colorectal Dis 2012; 27: 1657-1664.
  • 2.
    Gorey KM, Luginaah IN, Bartfay E, Fung KY, Holowaty EJ, Wright FC, et al. Effects of socioeconomic .status on colon cancer treatment accessibility and survival in Toronto, Ontario, and San Francisco, California 1996-2006. Am J Public Health 2011; 101: 112-119.
  • 3.
    Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 2006; 78: 4430-4442.##.
  • 4.
    Wishart DS. Quantitative metabolomics using NMR. TrAC Trends Analy Chem 2008; 27: 228-237.
  • 5.
    Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed 2005; 18: 143-162.
  • 6.
    Spratlin JL, Serkova NJ, Eckhardt SG. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 2009; 15: 431-440.
  • 7.
    Madsen R, Lundstedt T, Trygg J. Chemometrics in metabolomics--a review in human disease diagnosis. Anal Chim Acta 2010; 659: 23-33.
  • 8.
    Qiu Y, Cai G, Su M, Chen T, Liu Y, Xu Y, et al. Urinary metabonomic study on colorectal cancer. J Proteome Res 2010; 9: 1627-1634.
  • 9.
    Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, et al. Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res 2012; 11: 1354-1363.
  • 10.
    Viant MR. Improved methods for the acquisition and interpretation of NMR metabolomic data. Biochem Biophys Res Commun 2003; 310: 943-948.
  • 11.
    Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, et al. HMDB 3.0--The human metabolome database in 2013. Nucleic Acids Res 2013; 41: D801-807.
  • 12.
    Zamani Z, Arjmand M, Vahabi F, Eshaq Hosseini SM, Fazeli SM, Iravani A, et al. A metabolic study on colon cancer using (1)h nuclear magnetic resonance spectroscopy. Biochem Res Int 2014; 2014: 348712.
  • 13.
    Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS. MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysis. Nucleic Acids Res 2012; 40: W127-133.
  • 14.
    Mahdavinia M, Bishehsari F, Ansari R, Norouzbeigi N, Khaleghinejad A, Hormazdi M, et al. Family history of colorectal cancer in Iran. BMC Cancer 2005; 5: 112.
  • 15.
    Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B. Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed 2009; 22: 342-348.
  • 16.
    Yang XD, Ai W, Asfaha S, Bhagat G, Friedman RA, Jin G, et al. Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat Med 2011; 17: 87-95.
  • 17.
    Garcia-Caballero M, Neugebauer E, Campos R, Nunez de Castro I, Vara-Thorbeck C. Increased histidine decarboxylase (HDC) activity in human colorectal cancer: results of a study on ten patients. Agents Actions 1988; 23: 357-360.
  • 18.
    Guo M, Yang XL, Schimmel P. New functions of aminoacyl-tRNA synthetases beyond translation. Nat Rev Mol Cell Biol 2010; 11: 668-674.
  • 19.
    Kim S, You S, Hwang D. Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping. Nat Rev Cancer 2011; 11: 708-718.
  • 20.
    Reidling JC, Said HM. Adaptive regulation of intestinal thiamin uptake: molecular mechanism using wild-type and transgenic mice carrying hTHTR-1 and -2 promoters. Am J Physiol Gastrointest Liver Physiol 2005; 288: G1127-1134.
  • 21.
    Zastre JA, Sweet RL, Hanberry BS, Ye S. Linking vitamin B1 with cancer cell metabolism. Cancer Metab 2013; 1: 16.

Copyright

© 2016, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

6
Mar
2021
Survey of potential diagnostic metabolite markers in serum of the rat model of Alzheimer’s disease using nuclear magnatic resonance (1H-NMR) technique

Survey of potential diagnostic metabolite markers in serum of the rat model of Alzheimer’s disease using nuclear magnatic resonance (1H-NMR) technique

F fgoshadrou@yahoo.com,
Reyhaneh Farrokhi-Yekta,
Afsaneh ArefiOskouie,
Maryam Eslami

fgoshadrou@yahoo.com F, Farrokhi-Yekta R, ArefiOskouie A, Eslami M. Survey of potential diagnostic metabolite markers in serum of the rat model of Alzheimer’s disease using nuclear magnatic resonance (1H-NMR) technique. koomesh. 2021;23(1):e153245. doi:

17
Jul
2022
Evaluation of Enterococcus faecalis, Lactobacillus acidophilus, and Lactobacillus plantarum in Biopsy Samples of Colorectal Cancer and Polyp Patients Compared to Healthy People

Evaluation of Enterococcus faecalis, Lactobacillus acidophilus, and Lactobacillus plantarum in Biopsy Samples of Colorectal Cancer and Polyp Patients Compared to Healthy People

Masoud Dadashi,
Abolfazl Sahebi,
Reza Arjmand-Teymouri,
Mehdi Mirzaii,
Mehdi Mousavian,
Somayeh Yaslianifard

Dadashi M, Sahebi A, Arjmand-Teymouri R, Mirzaii M, Mousavian M, et al. Evaluation of Enterococcus faecalis, Lactobacillus acidophilus, and Lactobacillus plantarum in Biopsy Samples of Colorectal Cancer and Polyp Patients Compared to Healthy People. Arch Clin Infect Dis. 2022;17(1):e116165. doi: https://doi.org/10.5812/archcid-116165

7
Jul
2022
Clinical application of gut microbiota metabolites: A novel opportunity in personalized medicine

Clinical application of gut microbiota metabolites: A novel opportunity in personalized medicine

Zahra Hoseini Tavassol,
Hanieh-Sadat Ejtahed,
Ahmadreza Soroush,
Arefeh Shahriari,
Seyed Davar Siadat,
Shirin Hasani Ranjbar
,et al.

Hoseini Tavassol Z, Ejtahed H, Soroush A, Shahriari A, Siadat SD, et al. Clinical application of gut microbiota metabolites: A novel opportunity in personalized medicine. koomesh. 2022;24(2):e152661. doi:

29
May
2024
The Frequency of Verrucomicrobia in the Intestinal Mucus of Patients with Cancer and Polyps Compared to Healthy Individuals

The Frequency of Verrucomicrobia in the Intestinal Mucus of Patients with Cancer and Polyps Compared to Healthy Individuals

Afsaneh Hajimohammad,
Esmail Fattahi,
Abdollah Ardebili,
Hami Kaboosi,
Ezzat Allah Ghaemi

Hajimohammad A, Fattahi E, Ardebili A, Kaboosi H, Ghaemi EA. The Frequency of Verrucomicrobia in the Intestinal Mucus of Patients with Cancer and Polyps Compared to Healthy Individuals. Jundishapur J Microbiol. 2024;17(5):e146159. doi: https://doi.org/10.5812/jjm-146159

25
May
2022
Microbiome Analysis in Patients with Colorectal Cancer by 16S Ribosomal RNA Sequencing in the Southeast of Iran

Microbiome Analysis in Patients with Colorectal Cancer by 16S Ribosomal RNA Sequencing in the Southeast of Iran

Hosseinali Abdi,
Dor Mohammad Kordi-Tamandani,
Milad Lagzian,
Alireza Bakhshipour

Abdi H, Kordi-Tamandani DM, Lagzian M, Bakhshipour A. Microbiome Analysis in Patients with Colorectal Cancer by 16S Ribosomal RNA Sequencing in the Southeast of Iran. Jundishapur J Microbiol. 2022;15(4):e121119. doi: https://doi.org/10.5812/jjm-121119

More by these authors

sedigheh sadeghiPubMedScholar
ayda iravaniPubMedScholar
mohammad arjmandPubMedScholar
farideh vahabiPubMedScholar
syedmahmood eshaghhoseiniPubMedScholar
akbar oghalaiPubMedScholar
fatemeh mirkhaniPubMedScholar
Zahra ZamaniPubMedScholar
Share
Cited by
Metrics